Tyra Biosciences Inc (TYRA)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Todd J. Harris
Employees:
20
2656 STATE STREET, CARLSBAD, CA 92008
(619) 728-4760

Tyra Biosciences, Inc. focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer.

Data derived from most recent annual or quarterly report
Market Cap 673.049 Million Shares Outstanding42.197 Million Avg 30-day Volume 58.656 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.3
Price to Revenue0.0 Debt to Equity0.0 EBITDA-53.606 Million
Price to Book Value1.3787 Operating Margin0.0 Enterprise Value105.944 Million
Current Ratio48.729 EPS Growth0 Quick Ratio47.953
1 Yr BETA 1.3522 52-week High/Low 16.0 / 4.93 Profit Margin0.0
Operating Cash Flow Growth-174.4419 Altman Z-Score26.9911 Free Cash Flow to Firm 0
Earnings Report2023-05-04

Are you looking for this stock instead?

View SEC Filings from TYRA instead.

View recent insider trading info

Tyra Biosciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding TYRA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TYRA

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-28 by HARRIS TODD
  • 4: filed on 2023-03-23 by HARRIS TODD
  • 4: filed on 2023-03-23 by BENSEN DANIEL
  • 4: filed on 2023-03-17 by HARRIS TODD
  • 4: filed on 2023-03-17 by TADA HIROOMI
  • 4: filed on 2023-02-23 by PATEL PIYUSH R.
  • 4: filed on 2023-01-03 by FUHRMAN ALAN
  • 3: filed on 2023-01-03 by FUHRMAN ALAN
  • 4: filed on 2022-10-14 by PATEL PIYUSH R.
  • 4: filed on 2022-09-19 by TADA HIROOMI

    • Events (8k)

  • 8-K: filed on 2023-03-22:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-01:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 8.01: Other Events
  • 8-K: filed on 2022-11-29:
    Item 8.01: Other Events
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-03:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    313.4 Thousand total shares from 11 transactions

    Exercise Derivative Conversion (M)

    47.9 Thousand total shares from 9 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    HARRIS TODD CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 1,701,276 2023-03-24 4

    BENSEN DANIEL CHIEF OPERATING OFFICER

    • Officer
    		 527,981 2023-03-21 2

    TADA HIROOMI CHIEF MEDICAL OFFICER

    • Officer
    		 83,130 2023-03-15 3

    PATEL PIYUSH R. CHIEF DEVELOPMENT OFFICER

    • Officer
    		 73,794 2023-02-21 4

    MVA INVESTORS, LLC

    DAVIS AARON I.

    • 10% Owner
    		 22,527 2023-02-09 1

    FUHRMAN ALAN CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-01-01 2

    VAN DEN BOOM ESTHER CHIEF FINANCIAL OFFICER

    • Officer
    		 240,542 2022-09-15 2

    HUDKINS ROBERT L. CHIEF TECHNOLOGY OFFICER

    • Officer
    		 273,576 2022-09-15 2

    SWANSON RONALD V. CHIEF SCIENTIFIC OFFICER

    • Officer
    		 378,254 2022-09-06 1

    MORE ROBERT J

    • Director
    		 14,500 2022-06-13 1

    KAPLAN GILLA

    • Director
    		 14,500 2022-06-13 1

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    RA CAPITAL NEXUS FUND, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • Director
    • 10% Owner
    		 14,500 2022-06-13 1

    KJELLSON NINA S

    • Director
    		 14,500 2022-06-13 1

    CHEN ISAN

    • Director
    		 14,500 2022-06-13 1

    SIMSON JAKE

    • Director
    		 14,500 2022-06-13 1

    SUBRAMONY SIDDARTH

    • Director
    • 10% Owner
    		 14,500 2022-06-13 1

    VERJEE REHAN

    • Director
    		 14,500 2022-06-13 1

    FAWAZ ALI D. GENERAL COUNSEL AND SECRETARY

    • Officer
    		 0 2022-05-16 2

    HEALY JOHN STEPHEN GENERAL COUNSEL AND SECRETARY

    • Officer
    		 0 2022-03-01 0

    BOXER CAPITAL, LLC

    BOXER ASSET MANAGEMENT INC.

    LEWIS JOSEPH

    • 10% Owner
    		 6,448,359 2021-12-17 0

    BOXER CAPITAL, LLC

    BOXER ASSET MANAGEMENT INC.

    LEWIS JOSEPH

    MVA INVESTORS, LLC

    DAVIS AARON I.

    • 10% Owner
    		 6,611,454 2021-09-17 0

    ALTA PARTNERS NEXTGEN FUND II MANAGEMENT, LLC

    ALTA PARTNERS NEXTGEN FUND II, L.P.

    HUDSON PETER A

    JANNEY DANIEL

    • 10% Owner
    		 4,080,296 2021-09-17 0

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND III LP

    • Director
    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 1,069,932 2021-09-17 0

    CANAAN XI L.P.

    CANAAN PARTNERS XI LLC

    CANAAN 2020+ CO-INVESTMENT L.P. SERIES 7

    CANAAN PARTNERS 2020+ CO-INVESTMENT LLC

    • 10% Owner
    		 4,409,991 2021-09-17 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-28 19:09:04 -0400 2023-03-28 M 2,779 d 403,864 direct

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-28 19:09:04 -0400 2023-03-28 S 2,779 $16.00 d 1,701,276 direct yes

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-28 19:09:04 -0400 2023-03-28 M 2,779 $2.25 a 1,704,055 direct

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-28 19:09:04 -0400 2023-03-27 M 2,963 d 406,643 direct

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-28 19:09:04 -0400 2023-03-27 S 2,963 $16.00 d 1,701,276 direct yes

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-28 19:09:04 -0400 2023-03-27 M 2,963 $2.25 a 1,704,239 direct

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-28 19:09:04 -0400 2023-03-24 M 170 d 409,606 direct

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-28 19:09:04 -0400 2023-03-24 S 170 $16.00 d 1,701,276 direct yes

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-28 19:09:04 -0400 2023-03-24 M 170 $2.25 a 1,701,446 direct

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-23 19:49:09 -0400 2023-03-23 M 2,800 $2.25 a 1,704,076 direct 0.1254 0.1254 2 0.0 1

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-23 19:49:09 -0400 2023-03-23 S 2,800 $16.00 d 1,701,276 direct yes 0.1254 0.1254 2 0.0 1

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-23 19:49:09 -0400 2023-03-23 M 2,800 d 409,776 direct

    BENSEN DANIEL - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:47:49 -0400 2023-03-23 M 4,827 d 247,402 direct

    BENSEN DANIEL - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:47:49 -0400 2023-03-23 S 4,827 $16.00 d 527,981 direct yes 0.1254 0.1254 2 0.0 1

    BENSEN DANIEL - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:47:49 -0400 2023-03-23 M 4,827 $0.61 a 532,808 direct 0.1254 0.1254 2 0.0 1

    BENSEN DANIEL - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:47:49 -0400 2023-03-22 M 3,800 d 252,229 direct

    BENSEN DANIEL - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:47:49 -0400 2023-03-22 S 3,800 $16.00 d 527,981 direct yes 0.1254 0.1254 2 0.0 1

    BENSEN DANIEL - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:47:49 -0400 2023-03-22 M 3,800 $0.61 a 531,781 direct 0.1254 0.1254 2 0.0 1

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-23 19:49:09 -0400 2023-03-22 M 4,043 d 412,576 direct

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-23 19:49:09 -0400 2023-03-22 S 4,043 $16.00 d 1,701,276 direct yes 0.1254 0.1254 2 0.0 1

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-23 19:49:09 -0400 2023-03-22 M 4,043 $2.25 a 1,705,319 direct 0.1254 0.1254 2 0.0 1

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-23 19:49:09 -0400 2023-03-21 M 12,393 d 416,619 direct

    BENSEN DANIEL - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:47:49 -0400 2023-03-21 M 14,100 $0.61 a 542,081 direct 0.1254 0.1254 2 0.0 1

    BENSEN DANIEL - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:47:49 -0400 2023-03-21 S 14,100 $16.00 d 527,981 direct yes 0.1254 0.1254 2 0.0 1

    BENSEN DANIEL - Officer CHIEF OPERATING OFFICER

    		2023-03-23 19:47:49 -0400 2023-03-21 M 14,100 d 256,029 direct

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-23 19:49:09 -0400 2023-03-21 S 12,393 $16.00 d 1,701,276 direct yes 0.1254 0.1254 2 0.0 1

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-23 19:49:09 -0400 2023-03-21 M 12,393 $2.25 a 1,713,669 direct 0.1254 0.1254 2 0.0 1

    TADA HIROOMI - Officer CHIEF MEDICAL OFFICER

    		2023-03-17 17:27:33 -0400 2023-03-15 A 1,893 $6.58 a 83,130 direct 0.7571 0.7571 0.7571 2 -4.2902 3

    HARRIS TODD - Director - Officer CHIEF EXECUTIVE OFFICER

    		2023-03-17 17:28:32 -0400 2023-03-15 A 1,808 $6.58 a 1,701,276 direct 0.7571 0.7571 0.7571 2 -4.2902 3

    PATEL PIYUSH R. - Officer CHIEF DEVELOPMENT OFFICER

    		2023-02-23 18:16:24 -0500 2023-02-21 G 8,442 d 73,794 direct 13.4981 15.3042 25.5703 3 0.0 1

    MVA INVESTORS, LLC - > 10% Owner

    DAVIS AARON I. - > 10% Owner

    		2023-02-13 21:39:49 -0500 2023-02-10 S 65,568 $13.40 d 22,527 direct -0.3195 -9.9042 7.4281 3 -9.9042 6

    MVA INVESTORS, LLC - > 10% Owner

    DAVIS AARON I. - > 10% Owner

    		2023-02-13 21:39:49 -0500 2023-02-09 S 200,000 $13.10 d 88,095 direct -0.3195 -9.9042 7.4281 3 -9.9042 6

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    TYRA BIOSCIENCES INC TYRA 2023-03-28 22:15:04 UTC -2.0191 6.8391 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 21:45:03 UTC -2.0191 6.8391 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 21:15:04 UTC -2.0191 6.8391 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 20:45:04 UTC -2.0191 6.8391 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 20:15:04 UTC -2.0191 6.8391 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 19:45:05 UTC -2.0191 6.8391 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 19:15:04 UTC -2.0129 6.8329 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 18:45:04 UTC -2.0129 6.8329 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 18:15:03 UTC -2.0129 6.8329 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 17:45:04 UTC -2.0129 6.8329 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 17:15:03 UTC -2.0129 6.8329 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 16:45:04 UTC -2.0225 6.8425 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 16:15:03 UTC -2.0225 6.8425 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 15:45:04 UTC -2.0225 6.8425 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 15:15:04 UTC -2.0225 6.8425 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 14:45:03 UTC -2.0225 6.8425 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 14:15:04 UTC -2.0225 6.8425 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 13:45:03 UTC -2.0615 6.8815 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 13:15:04 UTC -2.0615 6.8815 15000
    TYRA BIOSCIENCES INC TYRA 2023-03-28 12:45:04 UTC -2.0615 6.8815 15000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TYRA -700.0 shares, $-5320.0 2022-12-31 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments